Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MRNA Marina Biotech Share Volume and Value Soar on Rumors of Patents and Presentations

HPNN, MEDT

Sometimes small companies that remain silent become the object of investors more so than those penny stocks that issue press releases daily.

One such company is MRNAMarina Biotech Inc. (OTC PINK: MRNA).

Volume and Share Price Surge

On Feb. 24, MRNAMarina Biotech’s stock volume soared, with 1,033,794 shares changing hands, 4.5 times greater than its three-month average volume of 229,117 shares.

The share price of this stock has been increasing lately, with no explanation from the company whatsoever. In fact, the last time it issued a press release was Dec. 6, 2012.

Mystery Company

The Bothell, Wash-based company, which is focused on developing and patenting complex nucleic acid-based therapies utilizing gene silencing approaches such as RNA interference, offers no information about its comings and goings. In fact, it lists a PO Box for its address.

MRNAMarina’s financials from 2011 report a $29 million loss that year. There have been unfounded rumors that the company recently was granted a patent from the Japanese and that its presentation at the 2014 Biotech Showcase in San Francisco in January caught some eyes.

MRNA’s share value closed at $1.42 on Feb 24, up 15 cents, from its close of $1.27 the previous day.

Find out what could be the best investor’s move when it comes to MRNA by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com

Hop-On Signs a Patent Licensing Agreement With Microsoft

Hop-On Inc. (OTCPINK: HPNN) share volume also soared Feb. 24 with a volume of 628,091,520, more than twice its three-month volume of 288,148,667 shares.

The surge in volume appears to be tied to a Feb. 20 press release outlining an agreement between the Temecula, Calif. wireless technology company and software giant Microsoft Corp.

According to the release, Microsoft Corp. and Hop-on, Inc., signed a worldwide patent licensing agreement that provides broad coverage under Microsoft's patent portfolio for devices running the Android and Chrome OS, including smartphones and tablets. While the contents of the agreement are confidential, the parties indicated that Microsoft will receive royalties from Hop-on under the agreement.

HPNN’s share value closed at 0.0008 cents on Feb 24, down 0.0006 cents, from its close of 0.0014 cents the previous day.

Find out what could be the best investor’s move when it comes to HPNN by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com

Refocusing On Developing Lights for Marijuana Industry

MediaTechnics Corp. (OTCPINK: MEDT) stock volume skyrocketed on Feb. 14, with 125,297,088 shares changing hands, nearly five times its three-month average volume of 26,836,668 shares.

The sudden uptick in volume and share price of this stock is being fueled by the first press release this company has issued since May of 2008.

New Chief Executive Takes Reins

In the Feb. 21 release, Media Technics announced a new chief executive taking over the reins of the Beverly Hill, Calif-based company that is developing lighting for the legal-marijuana industry.

“Henri Atamian has stepped down as President and CEO and appointed Jeremy Carr as MEDT's president and sole director. Mr. Carr, who was a former director of MEDT, will oversee the review and publishing of the Company's 2013 and 2012 Financial Statements, as well as an updated Initial Company Information Statement and intends to publish them via OTC Markets in the near future,” the release said.

It continued: “Mr. Carr has extensive contacts in the industry and intends to lease lighting and hydroponic equipment to licensed marijuana related businesses that are fully comply with state marijuana laws, as well as overseeing the development of software and mobile apps for this growing industry.”

No Info

Aside from this long break in the company’s self-imposed silence, there is no further information available on this company.

MEDT’s share value closed at 0.0034 cents on Feb 24, up 0.0009 cents, from its close of 0.0025 cents the previous day.

Find out what could be the best investor’s move when it comes to MEDT by getting the complete report here, or by cutting and pasting the following link in your Web browser:

http://www.sixfigurestockpicks.com

ABOUT US:

Sixfigurestockpicks.com issues momentum alerts on stocks that can provide gains to day traders.

Sixfigurestockpicks.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.

Sixfigurestockpicks.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals DailyStockMotion.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the Sixfigurestockpicks.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.sixfigurestockpicks.com

Disclosure

Sixfigurestockpicks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today